We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKE icon
176
Oneok
OKE
$57.2B
$2.7M 0.03%
50,496
+31,195
+162% +$1.66M
ATO icon
177
Atmos Energy
ATO
$28.8B
$2.68M 0.03%
31,253
+15,428
+97% +$1.36M
SMG icon
178
ScottsMiracle-Gro
SMG
$3.82B
$2.67M 0.03%
24,921
+5,667
+29% +$566K
CVGW
179
DELISTED
Calavo Growers
CVGW
$2.63M 0.03%
31,199
+825
+3% +$60.8K
STAG icon
180
STAG Industrial
STAG
$7.38B
$2.63M 0.03%
96,211
+14,236
+17% +$398K
COR
181
DELISTED
Coresite Realty Corporation
COR
$2.62M 0.03%
23,003
+495
+2% +$56.4K
THO icon
182
Thor Industries
THO
$3.9B
$2.55M 0.03%
16,922
-34,900
-67% -$4.85M
IPAR icon
183
Interparfums
IPAR
$3.99B
$2.52M 0.03%
58,039
+670
+1% +$29.1K
OEC icon
184
Orion
OEC
$381M
$2.52M 0.03%
98,427
+22,815
+30% +$539K
GS icon
185
Goldman Sachs
GS
$300B
$2.51M 0.03%
9,868
-1,427
-13% -$350K
STE icon
186
Steris
STE
$22.3B
$2.48M 0.03%
28,317
-25
-0.1% -$2.23K
LLY icon
187
Eli Lilly
LLY
$1.02T
$2.47M 0.03%
29,273
+356
+1% +$30.3K
CL icon
188
Colgate-Palmolive
CL
$73.1B
$2.41M 0.02%
31,986
-3,769
-11% -$275K
IBM icon
189
IBM
IBM
$211B
$2.4M 0.02%
16,330
-201
-1% -$29.2K
HRC
190
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$2.35M 0.02%
27,910
– –
RMAX icon
191
RE/MAX Holdings
RMAX
$193M
$2.35M 0.02%
48,380
-370
-0.8% -$21.1K
PEGA icon
192
Pegasystems
PEGA
$5.02B
$2.34M 0.02%
99,248
-5,200
-5% -$140K
MDLZ icon
193
Mondelez International
MDLZ
$79.5B
$2.33M 0.02%
54,513
+13,494
+33% +$567K
IVV icon
194
iShares Core S&P 500 ETF
IVV
$878B
$2.32M 0.02%
8,624
+3,867
+81% +$1.01M
ATR icon
195
AptarGroup
ATR
$8.55B
$2.31M 0.02%
26,775
– –
VMI icon
196
Valmont Industries
VMI
$9.3B
$2.31M 0.02%
13,898
+240
+2% +$39K
WAB icon
197
Wabtec
WAB
$49.1B
$2.29M 0.02%
28,182
-13,251
-32% -$1.01M
CCMP
198
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$2.29M 0.02%
24,338
+13,303
+121% +$1.22M
WSM icon
199
Williams-Sonoma
WSM
$26.9B
$2.27M 0.02%
87,722
+14,236
+19% +$363K
IJR icon
200
iShares Core S&P Small-Cap ETF
IJR
$109B
$2.26M 0.02%
29,426
-791
-3% -$59.6K
6 7
8
9 10

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.